1
|
Duarte F, Sousa T, Funke V, Colturato V, Hamerschlak N, Vilela N, Macedo M, Vigorito A, Soares R, Paz A, Stevenazzi M, Neto A, Bettarello G, Gusmão B, Salvino M, Calixto R, Moreira M, Teixeira G, Silva C, Lemes R, Garcia YO, Paton E, Rocha V, Enrico A, Bonfim C, Chiattone R, Simioni A, Arrais C, Coelho E, Diaz L. Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation -Bridging to transplantation. Leuk Res 2021. [DOI: 10.1016/j.leukres.2021.106681.54] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
2
|
Voltarelli C, Tan B, Costa L, Pasquini R, Funke V. SCOPULARIOSE INVASIVA EM PACIENTE IMUNOSSUPRIMIDO: RELATO DE CASO. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.491] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
3
|
Pagnano K, Toreli A, Perobelli L, Quixada A, Seguro F, Bendit I, Delamain M, Sapelli J, Moura M, Bortolini J, Lourenço A, Gonçalves N, Conchon M, Nucci F, Oliveira L, Magalhães G, Funke V, Tavares R, Centrone R, Santos F, Fogliatto L, Palma L, Clementino N, Hokama P, Boquimpani C. COVID-19 IN CHRONIC MYELOID LEUKEMIA PATIENTS – BRAZILIAN EXPERIENCE. Hematol Transfus Cell Ther 2020. [PMCID: PMC7603943 DOI: 10.1016/j.htct.2020.10.889] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
4
|
Imhoff FB, Funke V, Muench LN, Sauter A, Englmaier M, Woertler K, Imhoff AB, Feucht MJ. Correction to: The complexity of bony malalignment in patellofemoral disorders: femoral and tibial torsion, trochlear dysplasia, TT-TG distance, and frontal mechanical axis correlate with each other. Knee Surg Sports Traumatol Arthrosc 2020; 28:905. [PMID: 31227864 DOI: 10.1007/s00167-019-05564-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
The original article can be found online.
Collapse
Affiliation(s)
- Florian B Imhoff
- Department of Orthopaedic Sports Medicine, Technical University of Munich, Ismaningerstr. 22, 81675, Munich, Germany
| | - Victor Funke
- Department of Orthopaedic Sports Medicine, Technical University of Munich, Ismaningerstr. 22, 81675, Munich, Germany
| | - Lukas N Muench
- Department of Orthopaedic Sports Medicine, Technical University of Munich, Ismaningerstr. 22, 81675, Munich, Germany
| | - Andreas Sauter
- Department of Diagnostic and Interventional Radiology, Technical University of Munich, Ismaningerstr 22, Munich, 81675, Germany
| | - Maximilian Englmaier
- Department of Diagnostic and Interventional Radiology, Technical University of Munich, Ismaningerstr 22, Munich, 81675, Germany
| | - Klaus Woertler
- Department of Diagnostic and Interventional Radiology, Technical University of Munich, Ismaningerstr 22, Munich, 81675, Germany
| | - Andreas B Imhoff
- Department of Orthopaedic Sports Medicine, Technical University of Munich, Ismaningerstr. 22, 81675, Munich, Germany.
| | - Matthias J Feucht
- Department of Orthopaedic Sports Medicine, Technical University of Munich, Ismaningerstr. 22, 81675, Munich, Germany
| |
Collapse
|
5
|
Bonfim C, Ribeiro L, Loth G, Bitencourt M, Kanaan S, Koliski A, Funke V, Pilonetto D, Zanis-Neto J, Pasquini R. Unrelated Bone Marrow Transplantation (UBMT) for Children and Adolescents with Fanconi Anemia (FA) Using Cyclophophamide, Fludarabine and Rabbit ATG: Analysis of 33 Patients Transplanted at a Single Institution. Biol Blood Marrow Transplant 2012. [DOI: 10.1016/j.bbmt.2011.12.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
6
|
Vasconcelos R, Fortier S, Cunha C, Piazzera F, Morando J, Bitencourt M, Pasquini R, Zanis Neto J, Funke V, Bonfim C. Toxoplasma Gondii Infection In 34 pts Submitted To Hematopoietic Stem Cell Transplantation: Analysis From A Single Institution. Biol Blood Marrow Transplant 2010. [DOI: 10.1016/j.bbmt.2009.12.356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
7
|
Bittencourt H, Funke V, Fogliatto L, Magalhães S, Setubal D, Paz A, Macedo AV, Ruiz J, Azambuja AP, Silla L, Clementino N, Pasquini R. Imatinib mesylate versus allogeneic BMT for patients with chronic myeloid leukemia in first chronic phase. Bone Marrow Transplant 2008; 42:597-600. [DOI: 10.1038/bmt.2008.218] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
8
|
Bonfim C, Koliski A, Bitencourt M, Quiroga M, Setubal D, Funke V, Ruiz J, Medeiros L, Oliveira M, Coutinho E, Zanis Neto J, de Medeiros C, Pasquini R. 215: Hematopoietic Stem Cell Transplantation (HSCT) in Wiskott Aldrich Syndrome (WAS): A Single Center Experience in 25 Patients. Biol Blood Marrow Transplant 2008. [DOI: 10.1016/j.bbmt.2007.12.224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
9
|
Bonfim C, Bitencourt M, Setubal D, Funke V, Ruiz J, Oliveira M, Coutinho E, deMedeiros C, Zanis-Neto J, Pasquini R. 65: The use of cyclophosphamide (CY), fludarabine and ATG as a preparative regimen for unrelated cord blood transplantation (UCBT) in fanconi anemia. Biol Blood Marrow Transplant 2007. [DOI: 10.1016/j.bbmt.2006.12.068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
Bonfim C, Barriga F, Wietstruck M, Setubal D, Ruiz J, Funke V, Koliski A, Bitencourt M, Pasquini R. Stem cell transplantation (SCT) for patients with Wiskott Aldrich Syndrome (WAS): Analysis of 19 pts transplanted in Brazil and Chile. Biol Blood Marrow Transplant 2006. [DOI: 10.1016/j.bbmt.2005.11.391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Bonfim C, Bitencourt M, Funke V, Setubal D, Ruiz J, Doro M, Medeiros C, Zanis-Neto J, Pasquini R. Bone Marrow Transplantation (BMT) for heavily Transfused Patients (pts) with Severe Aplastic Anemia (SAA): 147 pts treated at the same institution with Busulfan (BU) + Cyclophosphamide (CY). Biol Blood Marrow Transplant 2006. [DOI: 10.1016/j.bbmt.2005.11.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
12
|
Bonfim C, Bitencourt M, Funke V, Setubal D, Ruiz J, Seber A, Pilonetto D, Medeiros C, Zanis-Neto J, Pasquini R. Stem cell transplantation in 40 pts with Fanconi anemia (FA): Excellent survival and low toxicity for pts with a related HLA identical donor. Biol Blood Marrow Transplant 2006. [DOI: 10.1016/j.bbmt.2005.11.380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
13
|
Bonfim C, Setubal D, Bitencourt M, Funke V, Ruiz J, Koliski A, Medeiros C, Zanis-Neto J, Pasquini R. High incidence of graft failure and transplant related mortality (TRM) in 50 children receiving unrelated umbilical cord blood transplantation (UCBT) for non-malignant diseases. Biol Blood Marrow Transplant 2006. [DOI: 10.1016/j.bbmt.2005.11.379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
14
|
Zanis-Neto J, Flowers MED, Medeiros CR, Bitencourt MA, Bonfim CM, Setúbal DC, Funke V, Sanders J, Deeg HJ, Kiem HP, Martin P, Leisenring W, Storb R, Pasquini R. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia. Br J Haematol 2005; 130:99-106. [PMID: 15982351 DOI: 10.1111/j.1365-2141.2005.05549.x] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Allogeneic haematopoietic cell transplantation (HCT) is effective therapy for Fanconi anaemia (FA). FA patients do not tolerate conditioning with 200 mg/kg of cyclophosphamide (Cy), typically used in aplastic anaemia. We previously published results of studies in which Cy doses were gradually reduced from 200 to 100 mg/kg. Here we update results of the initial studies and report data on 30 new patients conditioned with Cy either at 80 mg/kg (n = 7) or at 60 mg/kg (n = 23), given over 4 days before HCT from human leucocyte antigen-matched related donors. Methotrexate and cyclosporine were given for graft-versus-host disease (GVHD) prophylaxis. All seven patients given Cy at 80 mg/kg and 21 of 23 given Cy at 60 mg/kg had sustained engraftment, while two patients, both with clonal cytogenetics abnormalities, experienced graft failure. Grades 2-3 acute GVHD rates were 57% and 14% for patients given the higher and lower Cy doses, respectively (P = 0.001). Four patients given Cy at 80 mg/kg and 22 given Cy at 60 mg/kg were alive at a median of 47 (44-58) months and 16 (3-52) months, respectively. Cy at 60 mg/kg has acceptable toxicities, low rates of GVHD, and is sufficient for engraftment of related grafts in most FA patients.
Collapse
Affiliation(s)
- J Zanis-Neto
- The Bone Marrow Transplantation Center at the University of Parana, Curitiba, PA, Brazil
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Hirschman SZ, Funke V, Popper H. Effects of steroid hormones on replication of murine sarcoma virus in mouse embryo cultures. Exp Biol Med (Maywood) 1975; 149:790-5. [PMID: 167384 DOI: 10.3181/00379727-149-38900] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
The androgenic steroid hormone, testosterone, inhibited focus formation by the murine Moloney sarcoma virus in mouse embryo cells. The inhibition of focus formation was enhanced by cyclic AMP. Although focus formation was inhibited, there was no inhibition of viral replication. The glucogenic adrenal corticosteroids, cortisol and dexamethasone, and 17-beta-estradiol and progesterone did not affect focus formation by MuSV(M).
Collapse
|
16
|
Hirschman SZ, Funke V. Effect of diethylaminoethyl-dextran on the replication of a murine sarcoma (Moloney)-leukemia virus complex in mouse embryo cultures (38577). Exp Biol Med (Maywood) 1975; 148:527-31. [PMID: 164673 DOI: 10.3181/00379727-148-38577] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Isolates of a sarcoma (Moloney)-leukemia virus complex prepared as cell-free extracts from mouse tumors showed no enhancement in infectivity by DEAE-D either in the sarcoma moiety measured by focus formation or in the leukemia moiety measured by XC cell assay. The sarcoma moiety was not enhanced by DEAE-D in MEM and modified McCoy's 5a media or when varying amounts of FCS and glutamine were included in the media. Progressive enhancement of viral infectivity by DEAE-D was found when the viral preparations were passaged serially in MEF cells. DEAE-D ALSO ENHANCED TUMOR FORMATION IN VIVO BY TISSUE CULTURE PASSAGED VIRUS.
Collapse
|